Endoscopic Eradication Therapy for Patients with Barrett’s Esophagus–Associated Dysplasia and Intramucosal Cancer
Publication Date: February 1, 2018
Last Updated: March 14, 2022
Recommendations
1. In BE patients with LGD and HGD being considered for EET, we suggest confirmation of diagnosis by at least 1 expert GI pathologist or panel of pathologists compared with review by a single pathologist. (C, L)
620
Title
Endoscopic Eradication Therapy for Patients with Barrett’s Esophagus–Associated Dysplasia and Intramucosal Cancer
Authoring Organization
American Society for Gastrointestinal Endoscopy